Phase II trial of intraperitoneal cisplatin combined with paclitaxel in patients with ovarian, fallopian tube and primary peritoneal carcinomas

被引：0
|
作者：
Landrum, L.
Mannel, R.
McMeekin, D. [1 ]
Moore, K. [1 ]
Hyde, J.
Walker, J. [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
来源：
GYNECOLOGIC ONCOLOGY | 2010年 / 116卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
268
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [31] Deliverability of Carboplatin and Weekly Paclitaxel as Adjuvant Therapy for Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
    Sivakumaran, T.
    Zaheed, M.
    Freimund, A.
    Beale, P.
    Harrison, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 72 - 72
  • [32] A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma
    Campos, Susana M.
    Penson, Richard T.
    Matulonis, Ursula
    Horowitz, Neil S.
    Whalen, Christin
    Pereira, Lauren
    Tyburski, Karin
    Roche, Maria
    Szymonifka, Jackie
    Berlin, Suzanne
    GYNECOLOGIC ONCOLOGY, 2013, 128 (02) : 215 - 220
  • [33] Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Fu, Siqing
    Corr, Bradley R.
    Culm-Merdek, Kerry
    Mockbee, Colleen
    Youssoufian, Hagop
    Stagg, Robert
    Naumann, R. Wendel
    Wenham, Robert M.
    Rosengarten, Rafael D.
    Benjamin, Laura
    Hamilton, Erika Paige
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2568 - +
  • [34] A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer
    Konner, Jason
    Schilder, Russell J.
    DeRosa, Felicia A.
    Gerst, Scott R.
    Tew, William P.
    Sabbatini, Paul J.
    Hensley, Martee L.
    Spriggs, David R.
    Aghajanian, Carol A.
    GYNECOLOGIC ONCOLOGY, 2008, 110 (02) : 140 - 145
  • [35] A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel (Tax), IP cisplatin (Cis), and IV bevacizumab (Bev) as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
    Konner, J. A.
    Fallon, K.
    Pezzuli, S.
    Iasonos, A.
    Sabbatini, P.
    Hensley, M.
    Chiang, A.
    Tew, W.
    Spriggs, D.
    Aghajanian, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer
    Husain, A
    Sabbatini, P
    Spriggs, D
    Fennelly, D
    Aghajanian, C
    Barakat, R
    Curtin, J
    Venkatraman, E
    Hoskins, W
    Markman, M
    GYNECOLOGIC ONCOLOGY, 1999, 73 (01) : 96 - 101
  • [37] A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer
    Berkenblit, A
    Seiden, MV
    Matulonis, UA
    Penson, RT
    Krasner, CN
    Roche, M
    Mezzetti, L
    Atkinson, T
    Cannistra, SA
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 624 - 631
  • [38] Phase II study of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, peritoneal, or fallopian tube cancer
    Penson, R. T.
    Kornblith, A. B.
    Lee, J.
    Roche, M.
    Atkinson, T.
    Gibson, C. D.
    Horowitz, N. S.
    Krag, K. J.
    Krasner, C. N.
    Matulonis, U. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] A Randomized Phase II/III Trial of 3 Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with Intravenous Weekly Dose-dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian Tube and Primary Peritoneal Cancer
    Fujiwara, Keiichi
    Aotani, Eriko
    Hamano, Tetsutaro
    Nagao, Shoji
    Yoshikawa, Hiroyuki
    Sugiyama, Toru
    Kigawa, Junzo
    Aoki, Daisuke
    Katsumata, Noriyuki
    Takeuchi, Masahiro
    Suzuki, Mitsuaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (02) : 278 - 282
  • [40] Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
    Sabbatini, P
    Aghajanian, C
    Dizon, D
    Anderson, S
    Dupont, J
    Brown, JV
    Peters, WA
    Jacobs, A
    Mehdi, A
    Rivkin, S
    Eisenfeld, AJ
    Spriggs, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4523 - 4531
12345